Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for impact on inferior vena cava collapse index after anesthesia induction
ChiCTR2300070911Phase 4Not yet recruiting
- Sponsor
- Wenzhou People's Hospital
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam (2 arms), sponsored by Wenzhou People's Hospital. Primary endpoint: Inferior vena cava collapse index after anesthesia induction. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2300070911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070911.